手针与假针及常规护理预防无先兆发作性偏头痛的多中心随机临床试验
该多中心随机对照试验纳入150例无先兆发作性偏头痛且未接受过针灸治疗的患者,比较8周内20次手针加常规护理、假针加常规护理与单纯常规护理的预防效果。结果显示手针在减少偏头痛天数与发作次数方面优于假针和常规护理,无严重不良事件,支持手针用于不愿或药物无效的患者。
要点
- 手针在13-20周减少偏头痛天数优于假针,17-20周减少发作次数优于假针。
- 手针与假针的针感穿透感知比例无显著差异,提示盲法实施较好。
- 无严重不良事件报告,手针可作为不愿或药物无效患者的预防选择。
核心结论
- 20次手针治疗在预防无先兆发作性偏头痛方面优于假针和常规护理。
- 结果支持手针用于不愿使用预防药物或预防药物无效的患者。
研究设计与样本
- 多中心、随机、对照临床试验,参与者、结局评估和统计人员设盲。
- 中国7家医院,2016年6月5日至2018年11月15日,纳入150例无先兆发作性偏头痛且未接受过针灸治疗的患者。
- 干预为8周内20次手针加常规护理、20次非穿透假针加常规护理或单纯常规护理。
主要发现
- 150例随机患者平均年龄36.5(SD 11.4)岁,123例(82%)为女性,147例纳入全分析集。
- 13-16周偏头痛天数减少:手针3.5(SD 2.5)天 vs 假针2.4(3.4)天,校正差值-1.4(95%CI -2.4至-0.3;P=0.005)。
- 17-20周偏头痛天数减少:手针3.9(3.0)天 vs 假针2.2(3.2)天,校正差值-2.1(-2.9至-1.2;P<0.001)。
- 17-20周发作次数减少:手针2.3(1.7)次 vs 假针1.6(2.5)次,校正差值-1.0(-1.5至-0.5;P<0.001)。
- 无严重不良事件报告;手针与假针感知针穿透比例79% vs 75%(P=0.891)。
关键数值与推荐
- 主要结局为随机化后1-20周每4周偏头痛天数与发作次数较基线(随机化前4周)的变化。
- 手针在13-20周减少偏头痛天数显著优于假针,在17-20周减少发作次数显著优于假针。
临床怎么用
- 对于不愿使用预防药物或预防药物无效的无先兆发作性偏头痛患者,可考虑20次手针治疗。
- 手针治疗未报告严重不良事件,安全性可接受。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the efficacy of manual acupuncture as prophylactic treatment for acupuncture naive patients with episodic migraine without aura. DESIGN: Multicentre, randomised, controlled clinical trial with blinded participants, outcome assessment, and statistician. SETTING: Seven hospitals in China, 5 June 2016 to 15 November 2018. PARTICIPANTS: 150 acupuncture naive patients with episodic migraine without aura. INTERVENTIONS: 20 sessions of manual acupuncture at true acupuncture points plus usual care, 20 sessions of non-penetrating sham acupuncture at heterosegmental non-acupuncture points plus usual care, or usual care alone over 8 weeks. MAIN OUTCOME MEASURES: Change in migraine days and migraine attacks per four weeks during weeks 1-20 after randomisation compared with baseline (four weeks before randomisation). RESULTS: Among 150 randomised patients (mean age 36.5 (SD 11.4) years; 123 (82%) women), 147 were included in the full analysis set. Compared with sham acupuncture, manual acupuncture resulted in a significantly greater reduction in migraine days at weeks 13 to 20 and a significantly greater reduction in migraine attacks at weeks 17 to 20. The reduction in mean number of migraine days was 3.5 (SD 2.5) for manual versus 2.4 (3.4) for sham (adjusted difference -1.4, 95% confidence interval -2.4 to -0.3; P=0.005) at weeks 13 to 16 and 3.9 (3.0) for manual versus 2.2 (3.2) for sham (adjusted difference -2.1, -2.9 to -1.2; P<0.001) at weeks 17 to 20. At weeks 17 to 20, the reduction in mean number of attacks was 2.3 (1.7) for manual versus 1.6 (2.5) for sham (adjusted difference -1.0, -1.5 to -0.5; P<0.001). No severe adverse events were reported. No significant difference was seen in the proportion of patients perceiving needle penetration between manual acupuncture and sham acupuncture (79% v 75%; P=0.891). CONCLUSIONS: Twenty sessions of manual acupuncture was superior to sham acupuncture and usual care for the prophylaxis of episodic migraine without aura. These results support the use of manual acupuncture in patients who are reluctant to use prophylactic drugs or when prophylactic drugs are ineffective, and it should be considered in future guidelines. TRIAL REGISTRATION: Clinicaltrials.gov NCT02765581.
引用
- Xu S, Yu L, Luo X, et al. Manual acupuncture versus sham acupuncture and usual care for prophylaxis of episodic migraine without aura: multicentre, randomised clinical trial. BMJ. 2020. PMID: 32213509. doi:10.1136/bmj.m697
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。